Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 0.5595 -0.0204 (-3.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Kezar Life Sciences Inc < Previous 1 2 3 4 5 6 Next > Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session June 28, 2022 Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga Occidental Petroleum (OXY) Stock Gets Boost From Yet Another Buffett Buy June 28, 2022 Occidental Petroleum (OXY) stock is rising on Tuesday after Warren Buffett's Berkshire Hathaway increased its stake in the company. Via InvestorPlace Kezar Life Sciences (KZR) Stock Soars on Lupus Trial Results June 28, 2022 KZR stock is soaring today on news that Kezar Life Sciences' Lupus treatment showed positive results in a clinical trial. Via InvestorPlace Markets Open Higher; US Goods Gap Narrows To $104.3B In May June 28, 2022 U.S. stocks traded higher this morning, with the Dow Jones gaining over 350 points on Tuesday. Via Benzinga Wells Fargo Analyst Has Questions On Kezar's Lupus Nephritis Data Readout, Stock Plunges May 04, 2022 Via Benzinga Kezar Life's Lead Asset Fails To Top Placebo In Muscle Inflammation Disease May 04, 2022 Via Benzinga Why Kezar Life Sciences Stock Is Soaring Today June 28, 2022 Kezar Life Sciences Inc (NASDAQ: KZR) shares are surging Tuesday after the company announced topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib. Via Benzinga The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives June 28, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 28, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 28, 2022 Good morning! It's time for another dive into the biggest pre-market stock movers as we go over the news for Tuesday morning! Via InvestorPlace Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session June 28, 2022 Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session June 27, 2022 Gainers Via Benzinga Kezar Life Shares Shoot Higher After Positive Results From Mid-Stage Study Of Kidney Disease Candidate June 27, 2022 Kezar Life Sciences, Inc. (NASDAQ: KZR) reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN). Via Benzinga After-Hours Action: Why Kezar Life Sciences Stock Is Soaring June 27, 2022 Kezar Life Sciences Inc (NASDAQ: KZR) shares are surging in Monday's after-hours session after the company announced topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib. Via Benzinga Kezar Life Sciences Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis June 27, 2022 From Kezar Life Sciences, Inc. Via Business Wire Billionaire Israel Englander Is Betting Big on These 5 Stocks June 24, 2022 Millennium Management's Israel Englander is in focus after the billionaire's fund purchased several stocks this month. Via InvestorPlace Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 03, 2022 From Kezar Life Sciences, Inc. Via Business Wire 3 Biotech Stocks to Buy Before They Boom June 01, 2022 It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. Via InvestorPlace The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More May 30, 2022 Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... Via Benzinga Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update May 12, 2022 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 05, 2022 From Kezar Life Sciences, Inc. Via Business Wire 81 Biggest Movers From Yesterday May 05, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday. Via Benzinga Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5% May 04, 2022 U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision. Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session May 04, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after... Via Benzinga Mid-Day Market Update: Dow Rises 100 Points; Lyft Shares Plummet May 04, 2022 U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. Via Benzinga Why Kezar Life Sciences Shares Are Getting Hammered May 04, 2022 Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading lower by 38.23% at $7.61 after the company announced top-line results from its PRESIDIO Phase 2 clinical trial of... Via Benzinga Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points May 04, 2022 U.S. stocks traded mixed this morning, with the Nasdaq dropping more than 100 points on Wednesday. Via Benzinga The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints May 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 04, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session May 03, 2022 Gainers Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.